Rapport Therapeutics, Inc. · NASDAQ:RAPP
BlackRock, Inc. reported a 5.03% stake in Rapport Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock, Inc. reported a 5.03% stake in Rapport Therapeutics, Inc., 2,397,549 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G).
- Stake
- 5.03%
- Shares
- 2,397,549
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.03% | 2,397,549 |